Breast cancer most common cancer claim for women in 2021: Vitality

Skin and soft tissue second most common cancer

Hemma Visavadia
clock • 1 min read

Breast cancer accounted for over half (51%) of all women cancer claims received in 2021, according to Vitality's upcoming Health Claims Insights Report.

The provider revealed that skin and soft tissue was second most common cancer for women (22%), accounting for over one in five of all claims. For men under 55-year-olds, skin and soft tissue cancers was the most common form of cancer claims (22%), while prostate cancer was the most common reason for claiming for men over 55 years-old (27%). The report reviewed all claims received by Vitality for cancer made in 2021, including those who needed surgery, chemotherapy, radiotherapy, biological and hormone therapies, bisphosphonate treatments as well as stem cell therapy. Notably, the d...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on PMI

PMI admissions hit fourth record year in a row: PHIN
PMI

PMI admissions hit fourth record year in a row: PHIN

Fifth consecutive year of growth

Jaskeet Briah
clock 10 June 2026 • 3 min read
Private health admissions up 23% since pre-pandemic: PHIN
PMI

Private health admissions up 23% since pre-pandemic: PHIN

953,000 admissions in 2025

Cameron Roberts
clock 02 June 2026 • 1 min read
PMI claims satisfaction rises despite consumer fall in trust
PMI

PMI claims satisfaction rises despite consumer fall in trust

Fairer Finance's Trust in PMI Index

Jaskeet Briah
clock 18 May 2026 • 3 min read